Point-of-Care Glucose Testing Market to Reach $4.8 Billion, Globally, by 2032 at 4.8% CAGR: Allied Market Research

Key Facts

According to the report, the global point-of-care glucose testing market was valued at $3.0 billion in 2022 and is estimated to reach $4.8 billion by 2032, exhibiting a CAGR of 4.8% from 2023 to 2032.
of Pages in Report 408 Segments covered Product Type, Application, End User, and Region Drivers An increase in diabetes incidence rates A rise in the geriatric population Technological advancement in diabetic monitoring devices An increased prevalence of diabetes risk factor Opportunities Increase in awareness for glucose monitoring devices Untapped market opportunities in the developing regions Restraints Inaccurate results COVID-19 Scenario: * The global point-of-care glucose testing market had a positive impact during the pandemic, owing to the rise in cases of diabetes and the surge in demand for self-monitoring glucose testing devices.
The type-2 diabetes segment is expected to lead the trail by 2032: Based on application, the type-2 diabetes segment held the major share in 2022, accounting for more than four-fifths of the global point-of-care glucose testing market revenue, and is expected to lead the trail by 2032.
The home care settings segment to rule the roost by 2032: Based on end user, the home care settings segment accounted for the largest share in 2022, contributing to more than half of the global point-of-care glucose testing market revenue, and is projected to rule the roost by 2032.